ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 71

Inhibition of Nuclear Pore Export Ameliorates Lupus via Modulation of Plasma Cell Generation and Survival

Javier Rangel-Moreno1, Maria de la luz Garcia-Hernandez 2, Teresa Owen 3, Jennifer Barnard 3, Bruce Goldman 3, Christopher Ritchlin 2, Douglas Widman 4, Savanna Gornisiewicz 4, Sharon Tamir 4 and Jennifer H Anolik 3, 1University of Rochester Medical center, Rochester, NY, 2Division of Allergy, Immunology and Rheumatology, Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, Rochester, NY, 3University of Rochester, Rochester, NY, 4Karyopharm Therapeutics, Newton, MA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Autoimmunity, Biologics, immune response, Lupus and nephritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: SLE – Animal Models Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: A major challenge in lupus is the elimination of autoreactive plasma cells, which amplify inflammation at peripheral sites via deposition of autoantibody-self antigen complexes. We previously reported that Selective Inhibitors of Nuclear Export (SINEs), developed to treat malignancies including multiple myeloma, prevented lupus nephritis in lupus prone mice (LPM). SINEs potently reduced spontaneous formation of germinal centers (GC) and generation of autoreactive plasma cells in the spleen of LPM. We hypothesized that SINEs mediate their effect by disrupting NF-kB signaling in stromal cells, compromising migration and positioning of T and B cells, and thus affecting production of GC-derived plasma cells. Furthermore, SINEs may directly target plasma cells in the spleen and bone marrow (BM).

Methods: We isolated nuclear and cytoplasmic fractions from splenic stromal cells, stimulated with TNFain the presence of SINEs, and evaluated sequestration of NF-kB signaling components in the nuclei by western blot. Fold changes in mRNA expression for stromal cell-derived homeostatic chemokines (HC) were calculated with quantitative PCR. Morphometric analysis of area covered by fluorescent signal revealed the
in vivo
effects of SINEs on splenic HC. Finally, we used flow cytometry to enumerate cycling and non-cycling splenic and BM plasma cells in Edu labelled LPM after short-term therapy with KPT-335 (7.5 mg/kg) or vehicle (n = 8 mice/group).

Results: We demonstrated a significant enrichment for I-kBain the nuclear fraction of stromal cells stimulated with TNFain the presence of SINEs, thus confirming blockade of NF-kB signaling. In addition, fold mRNA expression for CCL19 and CXCL13 – HC that attract CXCR7+T cells and CXCR5+B cells, was significantly reduced in stromal cells incubated with SINEs (Control vs treated, p=0.0028). There was a significant decrease in CXCL13 staining (Control vs treated, p< 0.0001) and the size of follicular dendritic cells networks (Control vs treated, p< 0.0001) in spleens of mice orally treated with KPT-350 at 7.5 mg/kg for 8 weeks (3 administrations/week). As expected, short-term SINE therapy (1 week, 3 administrations/week) caused a two-fold reduction in GC B cells and a significant decrease in T follicular helper cells (Control vs treated, p=0.0043). Of note, short-term SINE therapy caused a global and significant reduction in long-lived plasma cells in spleen (Control vs treated, p=0.004) and BM (Control vs treated, p=0.0071). Unexpectedly, cycling splenic plasmablasts and short-lived plasma cells in the BM were not affected by SINE.

Conclusion: Our data demonstrate that SINEs disrupt NF-kB- dependent production of HC by stromal cells, thus impairing GC formation and compromising autoreactive PC generation. In addition, SINEs have a direct impact on PC survival, including long-lived plasma cells in the BM.


ACR2019JRM


Disclosure: J. Rangel-Moreno, None; M. Garcia-Hernandez, None; T. Owen, None; J. Barnard, None; B. Goldman, None; C. Ritchlin, AbbVie, 2, 5, 9, Amgen, 2, 5, BMS, 5, Janssen, 5, Janssen Research & Development, LLC, 2, Lilly, 5, Novartis, 5, Pfizer, 2, Pfizer Inc, 5, UCB, 2, 5; D. Widman, Karyopharm Therapeutics, 3; S. Gornisiewicz, Karyopharm, 3; S. Tamir, Karyopharm Therapeutics, 3; J. Anolik, None.

To cite this abstract in AMA style:

Rangel-Moreno J, Garcia-Hernandez M, Owen T, Barnard J, Goldman B, Ritchlin C, Widman D, Gornisiewicz S, Tamir S, Anolik J. Inhibition of Nuclear Pore Export Ameliorates Lupus via Modulation of Plasma Cell Generation and Survival [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/inhibition-of-nuclear-pore-export-ameliorates-lupus-via-modulation-of-plasma-cell-generation-and-survival/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inhibition-of-nuclear-pore-export-ameliorates-lupus-via-modulation-of-plasma-cell-generation-and-survival/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology